Comparison of Integrin αvβ3 Expression and Glucose Metabolism in Primary and Metastatic Lesions in Cancer Patients: A PET Study Using 18F-Galacto-RGD and 18F-FDG
Authors:
- Ambros J. BeerABAmbros J. Beer
- Sylvie LorenzenSLSylvie Lorenzen
- Stephan MetzSMStephan Metz
- Ken HerrmannKHKen Herrmann
- Petra WatzlowikPWPetra Watzlowik
- Hans-Jürgen WesterHWHans-Jürgen Wester
- Christian PeschelCPChristian Peschel
- Florian LordickFLFlorian Lordick
- Markus SchwaigerMSMarkus Schwaiger
Open Access
- 12 December 2007
- journal article
- research article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 49 (1) , 22-29
Abstract
The expression of αvβ3 and glucose metabolism are upregulated in many malignant lesions, and both are known to correlate with an aggressive phenotype. We evaluated whether assessment of αvβ3 expression and of glucose metabolism with PET using 18F-galacto-RGD and 18F-FDG provides complementary information in cancer patients. Methods: Eighteen patients with primary or metastatic cancer (non–small cell lung cancer [NSCLC], n = 10; renal cell carcinoma, n = 2; rectal cancer, n = 2; others, n = 4) were examined with PET using 18F-galacto-RGD and 18F-FDG. Standardized uptake values (SUVs) were derived by volume-of-interest analysis. 18F-Galacto-RGD and 18F-FDG PET results were compared using linear regression analysis for all lesions (n = 59; NSCLC, n = 39) and for primaries (n = 14) and metastases to bone (n = 11), liver (n = 10), and other organs (n = 24) separately. Results: The sensitivity of 18F-galacto-RGD PET compared with clinical staging was 76%. SUVs for 18F-FDG ranged from 1.3 to 23.2 (mean ± SD, 7.6 ± 4.9) and were significantly higher than SUVs for 18F-galacto-RGD (range, 0.3–6.8; mean ± SD, 2.7 ± 1.5; P < 0.001). There was no significant correlation between the SUVs for 18F-FDG and 18F-galacto-RGD for all lesions (r = 0.157; P = 0.235) or for primaries, osseous or soft-tissue metastases separately (P > 0.05). For the subgroup of lesions in NSCLC, there was a weak correlation between 18F-FDG and 18F-galacto-RGD uptake (r = 0.353; P = 0.028). Conclusion: Tracer uptake of 18F-galacto-RGD and 18F-FDG does not correlate closely in malignant lesions. Whereas 18F-FDG PET is more sensitive for tumor staging, 18F-galacto-RGD PET warrants further evaluation for planning and response evaluation of targeted molecular therapies with antiangiogenic or αvβ3-targeted drugs.Keywords
This publication has 29 references indexed in Scilit:
- 18F-FDG uptake as a biologic factor predicting outcome in patients with resected non-small-cell lung cancerChinese Medical Journal, 2007
- A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancerBMC Cancer, 2006
- Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin αvβ3 Expression in ManClinical Cancer Research, 2006
- Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future DirectionsThe Oncologist, 2006
- Phase II Evaluations of Cilengitide in Asymptomatic Patients with Androgen-Independent Prostate Cancer: Scientific Rationale and Study DesignClinical Genitourinary Cancer, 2006
- Spotlight on Bevacizumab in Advanced Colorectal Cancer, Breast Cancer, and Non-Small Cell Lung Cancer1BioDrugs, 2006
- Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGDPLOS Medicine, 2005
- Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- [18F]Galacto-RGD: Synthesis, Radiolabeling, Metabolic Stability, and Radiation Dose EstimatesBioconjugate Chemistry, 2003
- Coregulation of Glucose Uptake and Vascular Endothelial Growth Factor (VEGF) in Two Small-Cell Lung Cancer (SCLC) Sublines In Vivo and In VitroNeoplasia, 2001